Assertio Therapeutics Inc (ASRT) — Long-term Investment Intensity
Assertio Therapeutics Inc (ASRT) has a Long-term Investment Intensity of 0.1% as of December 2022. Long-term investments of $268.00K represent 0.1% of total assets of $413.91 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See Assertio Therapeutics Inc book value and equity for net asset value and shareholders' equity analysis.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Assertio Therapeutics Inc Long-term Investment Intensity (2011–2022)
This chart shows how Assertio Therapeutics Inc's Long-term Investment Intensity has evolved across 9 annual periods from 2011 to 2022. As of December 2022, the intensity stands at 0.1%, reflecting long-term investments of $268.00K against total assets of $413.91 Million USD. Also explore balance sheet size of Assertio Therapeutics Inc for the complete picture of this company's asset base.
Annual Long-term Investment Intensity for Assertio Therapeutics Inc (2011–2022)
The table below presents the year-by-year Long-term Investment Intensity for Assertio Therapeutics Inc from 2011 to 2022, covering 9 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see Assertio Therapeutics Inc market cap and net worth.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2022 | 0.1% | $268.00K | $413.91 Million | ▼ -0.4 pp |
| 2021 | 0.5% | $1.58 Million | $326.55 Million | ▼ 0.0 pp |
| 2020 | 0.5% | $1.58 Million | $303.27 Million | ▼ -2.0 pp |
| 2019 | 2.5% | $13.06 Million | $527.17 Million | ▲ +1.2 pp |
| 2018 | 1.3% | $11.78 Million | $932.87 Million | ▲ +0.3 pp |
| 2014 | 1.0% | $6.96 Million | $711.07 Million | ▲ +0.2 pp |
| 2013 | 0.8% | $4.08 Million | $508.65 Million | ▼ -7.0 pp |
| 2012 | 7.8% | $11.08 Million | $141.65 Million | ▼ -24.8 pp |
| 2011 | 32.6% | $53.64 Million | $164.37 Million | — |